×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.

Active Investigations

There are many active research projects accessing and applying shared ADNI data. Use the search above to find specific research focuses on the active ADNI investigations. This information is requested annually as a requirement for data access.

Principal Investigator  
Principal Investigator's Name: Makoto Ishii
Institution: Weill Cornell Medical College
Department: Neurology
Country:
Proposed Analysis: Altered Metabolic Signaling in Alzheimer's Disease and Related Disorders Aim 1: To determine whether alterations in analytes found in plasma and CSF samples of mice models of AD are found in the ADNI study population. Aim 2: To determine whether alterations in analytes found in plasma and CSF samples of a human preclinical AD study population are also found in the ADNI study population. Aim 3: To determine whether alterations in plasma/CSF levels of metabolic hormones (e.g., insulin, leptin etc) correlate with alterations in CSF and neuroimaging AD biomarkers in ADNI study population.
Additional Investigators  
Investigator's Name: Alice Tao
Proposed Analysis: Altered Metabolic Signaling in Alzheimer's Disease and Related Disorders Aim 1: To determine whether alterations in analytes found in plasma and CSF samples of mice models of AD are found in the ADNI study population. Aim 2: To determine whether alterations in plasma/CSF levels of metabolic hormones correlate with alterations in CSF and neuroimaging AD biomarkers in ADNI study population. Aim 3: To determine if alterations in brain regions involved in systemic metabolism and its connections are found in ADNI study population.
Investigator's Name: Emily Eruysal
Proposed Analysis: Altered Metabolic Signaling in Alzheimer's Disease and Related Disorders Aim 1: To determine whether alterations in analytes found in plasma and CSF samples of mice models of AD are found in the ADNI study population. Aim 2: To determine whether alterations in plasma/CSF levels of metabolic hormones correlate with alterations in CSF and neuroimaging AD biomarkers in ADNI study population. Aim 3: To determine if alterations in brain regions involved in systemic metabolism are found in ADNI study population.
Investigator's Name: Harshil Bhavsar
Proposed Analysis: Altered Metabolic Signaling in Alzheimer's Disease and Related Disorders Aim 1: To determine whether alterations in analytes found in plasma and CSF samples of mice models of AD are found in the ADNI study population. Aim 2: To determine whether alterations in plasma/CSF levels of metabolic hormones correlate with alterations in CSF and neuroimaging AD biomarkers in ADNI study population. Aim 3: To determine if alterations in brain regions involved in systemic metabolism are found in ADNI study population.
Investigator's Name: Lina AL-Ani
Proposed Analysis: Altered Metabolic Signaling in Alzheimer's Disease and Related Disorders Aim 1: To determine whether alterations in analytes found in plasma and CSF samples of mice models of AD are found in the ADNI study population. Aim 2: To determine whether alterations in analytes found in plasma and CSF samples of a human preclinical AD study population are also found in the ADNI study population. Aim 3: To determine whether alterations in plasma/CSF levels of metabolic hormones (e.g., insulin, leptin etc) correlate with alterations in CSF and neuroimaging AD biomarkers in ADNI study population.
Investigator's Name: Nada Abdallah
Proposed Analysis: Altered Metabolic Signaling in Alzheimer's Disease and Related Disorders Aim 1: To determine whether alterations in analytes found in plasma and CSF samples of mice models of AD are found in the ADNI study population. Aim 2: To determine whether alterations in analytes found in plasma and CSF samples of a human preclinical AD study population are also found in the ADNI study population. Aim 3: To determine whether alterations in plasma/CSF levels of metabolic hormones (e.g., insulin, leptin etc) correlate with alterations in CSF and neuroimaging AD biomarkers in ADNI study population.